药品
肺癌
抗药性
药物输送
医学
癌症
药理学
肿瘤科
内科学
纳米技术
生物
材料科学
微生物学
作者
Yingchun Lu,Chunyu Wang,Bin Liu
出处
期刊:PubMed
日期:2024-11-20
卷期号:27 (11): 864-872
标识
DOI:10.3779/j.issn.1009-3419.2024.101.30
摘要
Lung cancer is one of the most malignant tumor, representing a significant threat to human health. In China, its mortality rate is the highest among all malignant tumors. The occurrence of drug resistance has resulted in unfavourable prognosis for patients with lung cancer, and overcoming drug resistance is a significant challenge that needs to be addressed. Nano-drug delivery technology has been an important approach to overcome drug resistance in lung cancer. Targeting to the mechanisms of drug resistance, by enabling the combined delivery of drugs, increasing the efficiency of drug delivery and improving the targeting and safety of drugs, nano-drug delivery technology offers a novel approach to tackling drug resistance in lung cancer. This paper describes the current status of lung cancer treatment, mechanisms of drug resistance, strategies to overcome drug resistance, and the application of nanotechnology in the diagnosis and treatment of lung cancer. In addition, it summarizes the recent research progress on the application of nano-drug delivery technology to overcome drug resistance in lung cancer. Finally, the current prospects and challenges of nano-drug delivery technology are discussed. .
科研通智能强力驱动
Strongly Powered by AbleSci AI